Griffith & Werner’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
15,091
+1,346
+10% +$177K 0.89% 30
2026
Q1
$1.92M Sell
13,745
-1,359
-9% -$190K 0.95% 31
2025
Q4
$1.85M Buy
15,104
+168
+1% +$20.4K 0.94% 31
2025
Q3
$1.76M Buy
+14,936
New +$1.7M 0.91% 31
2025
Q1
$1.55M Sell
13,832
-604
-4% -$62.3K 0.96% 29
2024
Q4
$1.33M Buy
+14,436
New +$1.3M 0.88% 30

Other funds holding GILD

Griffith & Werner's GILD Position: Q2 2026 in Review

Griffith & Werner increased its Gilead Sciences (GILD) stake by 9.8% in Q2 2026, buying an estimated $177K and bringing the position to 15,091 shares worth $1.91M. The position accounts for 0.89% of the portfolio, ranked #30.

Griffith & Werner first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.92M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Griffith & Werner held 15,091 shares of Gilead Sciences worth $1.91M as of Q2 2026.
  • Griffith & Werner bought 1,346 Gilead Sciences shares in Q2 2026, an estimated $177K.
  • Gilead Sciences made up 0.89% of Griffith & Werner's portfolio in Q2 2026, its #30 holding.
  • Griffith & Werner first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Griffith & Werner's Gilead Sciences position peaked at $1.92M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Griffith & Werner's 13F filing for Q2 2026, filed 30 Jul 2026.